Central Garden and Pet Co CENT

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

CENT hizo una división de acciones (split) de 5:4 el 9 de febrero de 2024: cada 4 acciones se convirtieron en 5. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 1 oct

  Is Central Garden & Pet (CENT) Stock Outpacing Its Consumer Discretionary Peers This Year?

  Central Garden & Pet (CENT) is significantly outperforming its Consumer Discretionary peers with a 21% year-to-date return compared to the sector's -14.6% average loss. The stock holds a Zacks Rank #2 (Buy) with improving analyst sentiment, as consensus earnings estimates have risen 3% in the past quarter. People Inc. (PPLI) is another outperformer in the sector with a 7.3% return and a stronger Zacks Rank #1 (Strong Buy) rating.

  

• Zacks Investment Research 1 oct

  Central Garden (CENT) Upgraded to Buy: Here's Why

  Central Garden (CENT) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company, which operates in pet supply and lawn and garden markets, has seen analysts steadily raise estimates over the past three months with a 3% increase in consensus estimates. The upgrade positions the stock in the top 20% of Zacks-covered stocks, suggesting potential near-term price appreciation.

  

• Zacks Investment Research 1 oct

  Should Value Investors Buy Central Garden & Pet (CENT) Stock?

  Central Garden & Pet (CENT) is identified as an attractive value stock with a Zacks Rank #2 (Buy) rating and an 'A' Value grade. Trading at a P/E ratio of 12.91 compared to its industry average of 13.85, and a P/B ratio of 1.38 versus the industry average of 2.83, the stock appears undervalued with a strong earnings outlook.

  

• Zacks Investment Research 29 sept

  Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds

  Chewy's Vet Care portfolio achieved triple-digit revenue growth in Q2, demonstrating strong customer satisfaction, veterinarian retention, and compelling clinic economics. The company expects its Health segment, including Modern Animal, to deepen customer engagement and expand wallet share as it scales. However, Chewy carries a Zacks Rank #4 (Sell) rating and has underperformed its industry by 44.7% over the past six months.

  

• Zacks Investment Research 29 sept

  Is Central Garden & Pet (CENTA) Stock Undervalued Right Now?

  Zacks identifies Central Garden & Pet (CENTA) as an attractive value stock, holding a Zacks Rank #2 (Buy) and Value grade of A. Trading at a P/E ratio of 11.58 compared to its industry average of 13.99, and a P/B ratio of 1.24 versus the industry average of 2.86, CENTA appears undervalued with a strong earnings outlook.